Tetrahydrocarbazole
![]() | |
| Names | |
|---|---|
| IUPAC name 2,3,4,9-tetrahydro-1H-carbazole | |
| Other names 1,2,3,4-Tetrahydrocarbazole | |
| Identifiers | |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.012.168 |
| EC Number |
|
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Tetrahydrocarbazole is a heterocyclic compound featuring a fused structure composed of a five-membered pyrrole ring, a benzene ring, and a cyclohexane ring, making it a partially saturated derivative of carbazole.[1] This molecular framework is commonly found in natural products and serves as a scaffold in medicinal chemistry due to its diverse pharmacological activities, including antimicrobial, anticancer, antipsychotic, and anti-inflammatory properties.[1]
Examples of drugs that contain the tetrahydrocarbazole ring system include ondansetron and ramatroban.
References
- ^ a b Chakroborty S, Panda P (September 2021). "A comprehensive overview of the synthesis of tetrahydrocarbazoles and its biological properties". Mini-Reviews in Organic Chemistry. 18 (6): 709–718. doi:10.2174/1570193X17999200820163532.
